Press Release
NARAL Pro-Choice America Responds as Supreme Court Again Delays Decision on Mifepristone
Washington, DC — Today, the U.S. Supreme Court issued a second administrative stay on lower court efforts meant to block access to medication abortion with mifepristone nationwide, delaying their decision for the second time.
NARAL Pro-Choice America President Mini Timmaraju released the following statement in response:
“As this case continues, safe and effective medication abortion with mifepristone in all 50 states remains in peril. The Supreme Court knows that siding with extreme Trump judges to restrict medication abortion will ignite the biggest political firestorm since Roe v. Wade was overturned. The anti-choice extremists on the Court need to throw in the towel and accept reality: the science, the facts, and the law are all on the side of legal and accessible medication abortion. The lower courts’ decisions have been entirely baseless.”
###
For over 50 years, NARAL Pro-Choice America has fought to protect and advance reproductive freedom at the federal and state levels—including access to abortion care, birth control, pregnancy and post-partum care, and paid family leave—for everybody. NARAL is powered by its 4 million members from every state and congressional district in the country, representing the 8 in 10 Americans who support legal abortion.